Pharma Group Sues Over La.'s Revisions To Drug Pricing
A group that represents major pharmaceutical companies has lobbed a suit claiming Louisiana wrongly passed a law that adds requirements on drugmakers beyond what is required under a multibillion-dollar federal drug...To view the full article, register now.
Already a subscriber? Click here to view full article